The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
Open accessAbstract
Damage to the mitotic spindle and centrosome dysfunction can lead to cancer. To prevent this, cells trigger a succession of checkpoint responses, where an initial mitotic delay is followed by slippage without cytokinesis, spawning tetraploid G1 cells that undergo a p53-dependent G1/S arrest. We describe the importance of Lats2 (Large Tumor Suppressor 2) in this checkpoint response. Lats2 binds Mdm2, inhibits its E3 ligase activity, and activates p53. Nocodazole, a microtubule poison that provokes centrosome/mitotic apparatus dysfunction, induces Lats2 translocation from centrosomes to the nucleus and p53 accumulation. In turn, p53 rapidly and selectively up-regulates Lats2 expression in G2/M cells, thereby defining a positive feedback loop. Abrogation of Lats2 promotes accumulation of polyploid cells upon exposure to nocodazole, which can be prevented by direct activation of p53. The Lats2–Mdm2–p53 axis thus constitutes a novel checkpoint pathway critical for the maintenance of proper chromosome number.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Self-citationDitchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., & Taylor, S. S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208091 · Cited by 1,194
Polo-like kinases and the orchestration of cell division
Barr, F. A., Silljé, H. H. W., & Nigg, E. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1401 · Cited by 1,087
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Self-citationDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Xu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
The p53–Mdm2 module and the ubiquitin system
Michael, D., & Oren, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00099-8 · Cited by 765
Self-citationCentrosome aberrations: cause or consequence of cancer progression?
Nigg, E. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc924 · Cited by 732
Rajagopalan, H., & Lengauer, C. (2004) · Nature · doi:10.1038/nature03099 · Cited by 725
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy
Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708
Mapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
Stuck in Division or Passing through
Rieder, C. L., & Maiato, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.002 · Cited by 657
Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption
Lanni, J. S., & Jacks, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1055 · Cited by 497
Assembly of centrosomal proteins and microtubule organization depends on PCM-1
Dammermann, A., & Merdes, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204023 · Cited by 489
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction
St John, M. A. R., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M. L., Brownstein, D. G., Parlow, A. F., McGrath, J., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5965 · Cited by 439
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
Scolnick, D. M., & Halazonetis, T. D. (2000) · Nature · doi:10.1038/35019108 · Cited by 375
Centrosome control of the cell cycle
Doxsey, S., Zimmerman, W., & Mikule, K. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.008 · Cited by 316
MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
Bond, G., Hu, W., & Levine, A. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332627 · Cited by 308
A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue
Kantor, D. B., Lanzrein, M., Stary, S. J., Sandoval, G. M., Smith, W. B., Sullivan, B. M., Davidson, N., & Schuman, E. M. (1996) · Science · doi:10.1126/science.274.5293.1744 · Cited by 304
Takahashi, Y., Miyoshi, Y., Takahata, C., Irahara, N., Taguchi, T., Tamaki, Y., & Noguchi, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1773 · Cited by 279
Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet, R., Petretti, C., & Prigent, C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.004 · Cited by 262
Vousden, K. H., & Prives, C. (2005) · Cell · doi:10.1016/j.cell.2004.12.027 · Cited by 259
G1 tetraploidy checkpoint and the suppression of tumorigenesis
Margolis, R. L., Lohez, O. D., & Andreassen, P. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10411 · Cited by 232
The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression
Minsky, N., & Oren, M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.016 · Cited by 204 · cited 2×
“Loading and transfection controls, GFP and Flag-H2B, were described previously (Minsky and Oren 2004).”
MethodSelf-citationCell cycle progression after cleavage failure
Uetake, Y., & Sluder, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403014 · Cited by 203
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity
McPherson, J. P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak‐Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600371 · Cited by 201
Lats2, a putative tumor suppressor, inhibits G1/S transition
Li, Y., Pei, J., Xia, H., Ke, H., Wang, H., & Tao, W. (2003) · Oncogene · doi:10.1038/sj.onc.1206603 · Cited by 199
Hirota, T., Morisaki, T., Nishiyama, Y., Marumoto, T., Tada, K., Hara, T., Masuko, N., Inagaki, M., Hatakeyama, K., & Saya, H. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.5.1073 · Cited by 196
Centrosome positioning in interphase cells
Burakov, A., Nadezhdina, E., Slepchenko, B., & Rodionov, V. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305082 · Cited by 195
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane
Hergovich, A., Schmitz, D., & Hemmings, B. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.244 · Cited by 185
P53 and PrognosisNew Insights and Further Complexity
VOUSDEN, K., & PRIVES, C. (2005) · Cell · doi:10.1016/s0092-8674(04)01252-8 · Cited by 173
LATS1 tumor suppressor regulates G2/M transition and apoptosis
Hong, X., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., & Tao, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205174 · Cited by 158
The centrosomal protein Lats2 is a phosphorylation target of Aurora‐A kinase
Toji, S., Yabuta, N., Hosomi, T., Nishihara, S., Kobayashi, T., Suzuki, S., Tamai, K., & Nojima, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00732.x · Cited by 145
Self-citationWong, C., & Stearns, T. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-6 · Cited by 140
Human LATS1 Is a Mitotic Exit Network Kinase
Bothos, J. G., Tuttle, R. L., Ottey, M., Luca, F. C., & Halazonetis, T. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0862 · Cited by 130
Yabuta, N., Fujii, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Nishiguchi, H., Endo, Y., Toji, S., Tanaka, H., Nishimune, Y., et al. (2000) · Genomics · doi:10.1006/geno.1999.6065 · Cited by 112
Self-citationNishiyama, Y., Hirota, T., Morisaki, T., Hara, T., Marumoto, T., Iida, S.-I., Makino, K., Yamamoto, H., Hiraoka, T., Kitamura, N., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01224-7 · Cited by 108
Jiménez‐Velasco, A., Román‐Gómez, J., Agirre, X., Barrios, M., Navarro, G., Vázquez, I., Prósper, F., Torres, A., & Heiniger, A. (2005) · Leukemia · doi:10.1038/sj.leu.2403974 · Cited by 102
Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-xL
Ke, H., Pei, J., Ni, Z., Hong, X., Qi, H., Woods, T., Kelekar, A., & Tao, W. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.031 · Cited by 99
Abe, Y., Ohsugi, M., Haraguchi, K., Fujimoto, J., & Yamamoto, T. S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.096 · Cited by 98
Iida, S.-I., Hirota, T., Morisaki, T., Marumoto, T., Hara, T., Kuninaka, S., Honda, S., Kosai, K.-I., Kawasuji, M., Pallas, D. C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207623 · Cited by 80
Guilt by association? p53 and the development of aneuploidy in cancer
Duensing, A. U., & Duensing, S. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.157 · Cited by 76
Kamikubo, Y., Takaori‐Kondo, A., Uchiyama, T., & Hori, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211974200 · Cited by 70
Hori, T., Takaori‐Kondo, A., Kamikubo, Y., & Uchiyama, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203659 · Cited by 69
Centrosome separation: respective role of microtubules and actin filaments
Uzbekov, R. E., Kireev, I. I., & Prigent, C. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(02)01202-9 · Cited by 68
Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
Dash, B. C., & El‐Deiry, W. S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:099 · Cited by 65
Triggering p53 after cytokinesis failure
Stukenberg, P. T. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200405089 · Cited by 65
Tarapore, P., Tokuyama, Y., Horn, H. F., & Fukasawa, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204848 · Cited by 56
Mammalian Sterile 20–Like Kinases in Tumor Suppression: An Emerging Pathway
O’Neill, E. E., Matallanas, D., & Kölch, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1453 · Cited by 54
G2 and spindle assembly checkpoint adaptation, and tetraploidy arrest:
Andreassen, P. R., Lohez, O. D., & Margolis, R. L. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.020 · Cited by 53
Isolation and characterization of sixteen novel p53 response genes
Kostic, C., & Shaw, P. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203747 · Cited by 43
Chromosome damage and progression into and through mitosis in vertebrates
Morrison, C. G., & Rieder, C. L. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.005 · Cited by 41
Cited by
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
Self-citationTetraploidy, aneuploidy and cancer
Ganem, N. J., Storchova, Z., & Pellman, D. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.02.011 · Cited by 668
Metadata
- Authors
- Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-10-01
- Volume
- 20
- Issue
- 19
- Pages
- 2687-2700
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2051200214
- Cited by
- 284
- References
- 61
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.